Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ardelyx, Inc. stock logo
ARDX
Ardelyx
$6.78
+2.6%
$7.29
$3.16
$10.13
$1.54B0.875.29 million shs3.30 million shs
CONMED Co. stock logo
CNMD
CONMED
$75.68
+1.9%
$73.99
$61.05
$138.47
$2.29B1.37413,632 shs414,818 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$20.36
+4.0%
$14.39
$5.65
$21.44
$4.21B0.9714.31 million shs19.10 million shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$11.29
+1.3%
$13.27
$11.00
$30.41
$1.89B0.974.62 million shs3.70 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ardelyx, Inc. stock logo
ARDX
Ardelyx
+2.57%-8.87%+5.94%-27.41%+102.99%
CONMED Co. stock logo
CNMD
CONMED
+1.98%+3.53%+11.31%-5.36%-37.60%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
+4.04%+28.66%+62.62%+55.18%+127.74%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+1.26%-1.35%-11.42%-24.71%-51.21%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ardelyx, Inc. stock logo
ARDX
Ardelyx
4.6592 of 5 stars
4.63.00.04.43.21.70.6
CONMED Co. stock logo
CNMD
CONMED
4.9128 of 5 stars
3.41.02.54.31.81.74.4
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.2109 of 5 stars
2.32.00.00.03.03.31.9
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.0169 of 5 stars
4.22.00.00.01.92.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ardelyx, Inc. stock logo
ARDX
Ardelyx
3.11
Buy$12.8188.97% Upside
CONMED Co. stock logo
CNMD
CONMED
2.83
Moderate Buy$102.5035.44% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.53
Moderate Buy$15.69-22.93% Downside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.33
Hold$18.2261.37% Upside

Current Analyst Ratings

Latest TDOC, HIMS, ARDX, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/24/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$15.00 ➝ $15.00
5/24/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$15.00 ➝ $15.00
5/22/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $24.00
5/22/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$16.00 ➝ $20.00
5/21/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.00
5/14/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.50 ➝ $13.50
5/7/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$14.00 ➝ $16.00
5/7/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $13.00
5/6/2024
CONMED Co. stock logo
CNMD
CONMED
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$107.00
5/3/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
5/3/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$14.00 ➝ $15.00
(Data available from 5/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ardelyx, Inc. stock logo
ARDX
Ardelyx
$124.46M12.68N/AN/A$0.65 per share10.43
CONMED Co. stock logo
CNMD
CONMED
$1.24B1.87$6.17 per share12.26$27.75 per share2.73
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$872M5.02N/AN/A$1.60 per share12.73
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.74$0.82 per share13.74$13.50 per share0.84

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ardelyx, Inc. stock logo
ARDX
Ardelyx
-$66.07M-$0.28N/A48.43N/A-41.36%-41.65%-23.08%8/7/2024 (Estimated)
CONMED Co. stock logo
CNMD
CONMED
$64.46M$2.6129.0013.740.716.53%13.78%4.86%7/24/2024 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$23.55M-$0.01N/A61.70N/A-0.24%-0.70%-0.55%8/5/2024 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.41N/AN/AN/A-8.90%-10.13%-5.37%7/23/2024 (Estimated)

Latest TDOC, HIMS, ARDX, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024Q1 2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.02$0.05+$0.03$0.05$270.37 million$278.20 million    
5/2/2024Q1 2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
-$0.13-$0.11+$0.02-$0.11$36.40 million$46.00 million    
4/25/2024Q1 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02-$0.49$637.31 million$646.13 million    
4/24/2024Q1 2024
CONMED Co. stock logo
CNMD
CONMED
$0.74$0.79+$0.05$0.95$307.06 million$312.27 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ardelyx, Inc. stock logo
ARDX
Ardelyx
N/AN/AN/AN/AN/A
CONMED Co. stock logo
CNMD
CONMED
$0.801.06%N/A30.65%N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Latest TDOC, HIMS, ARDX, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2024
CONMED Co. stock logo
CNMD
CONMED
Quarterly$0.201.09%6/14/20246/14/20247/5/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ardelyx, Inc. stock logo
ARDX
Ardelyx
0.66
4.53
4.36
CONMED Co. stock logo
CNMD
CONMED
1.16
2.18
1.08
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
2.80
2.48
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.82
3.74

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ardelyx, Inc. stock logo
ARDX
Ardelyx
58.92%
CONMED Co. stock logo
CNMD
CONMED
N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%

Insider Ownership

CompanyInsider Ownership
Ardelyx, Inc. stock logo
ARDX
Ardelyx
5.50%
CONMED Co. stock logo
CNMD
CONMED
6.80%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
17.71%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.95%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ardelyx, Inc. stock logo
ARDX
Ardelyx
267232.70 million219.90 millionOptionable
CONMED Co. stock logo
CNMD
CONMED
4,00030.80 million28.71 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,046214.79 million176.75 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.59 million167.98 millionOptionable

TDOC, HIMS, ARDX, and CNMD Headlines

Recent News About These Companies

LifeMD Can Surge on Its GLP-1 Offerings (TDOC)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Ardelyx logo

Ardelyx

NASDAQ:ARDX
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
CONMED logo

CONMED

NYSE:CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Hims & Hers Health logo

Hims & Hers Health

NYSE:HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.